Lv31
336 积分 2022-09-16 加入
Etelcalcetide: What we know eight years since its approval
5小时前
待确认
In vivo CAR T cell engineering: design principles and open questions
7天前
已完结
Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects
9天前
已完结
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
10天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
11天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
11天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
11天前
已完结
Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved Diseases
18天前
已完结
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
18天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
24天前
已完结
皖公网安备34019202002308
